State Street Corp Pulse Biosciences, Inc. Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 461,333 shares of PLSE stock, worth $8.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
461,333
Previous 391,637
17.8%
Holding current value
$8.35 Million
Previous $4.38 Million
84.64%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PLSE
# of Institutions
77Shares Held
5.39MCall Options Held
139KPut Options Held
84.2K-
Black Rock Inc. New York, NY1.15MShares$20.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$18 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC786KShares$14.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA457KShares$8.28 Million0.0% of portfolio
-
Griffin Asset Management, Inc.238KShares$4.3 Million0.53% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $672M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...